Literature DB >> 3734238

Trends in the presentation and treatment of basal cell carcinomas.

R K Roenigk, J L Ratz, P L Bailin, R G Wheeland.   

Abstract

Analysis of 1,620 basal cell carcinomas treated at the Cleveland Clinic Foundation from 1981 to 1983 confirms that the majority of basal cell carcinomas occur on the face and that the relative risk for recurrent tumor is high in certain locations, especially the nose. Alternately, tumors found on the neck/scalp, trunk, and arms have a low relative risk of recurrence when compared to all other anatomic locations. More primary and fewer recurrent tumors now presenting to our unit have been referred for Mohs surgery as primary therapy. This results in higher cure rates for treatment of all basal cell carcinoma.

Entities:  

Mesh:

Year:  1986        PMID: 3734238     DOI: 10.1111/j.1524-4725.1986.tb01993.x

Source DB:  PubMed          Journal:  J Dermatol Surg Oncol        ISSN: 0148-0812


  15 in total

1.  [Secondary wound healing. Effective treatment concept after basal cell carcinoma resection in the central midface].

Authors:  T K Hoffmann; J Arnolds; P J Schuler; E Kultas; J Greve; N Mansour; M Bas; S Lang; A Hilpert
Journal:  HNO       Date:  2012-07       Impact factor: 1.284

2.  More on Mohs'.

Authors:  H K Steinman
Journal:  West J Med       Date:  1990-12

Review 3.  Diagnosis and Management of Basal Cell Carcinoma.

Authors:  Keiji Tanese
Journal:  Curr Treat Options Oncol       Date:  2019-02-11

4.  Obtaining high cure rates for challenging facial malignancies: A new method for producing rapid, accurate, high-quality frozen sections.

Authors:  Kirsty Boyd; Colin Henderson; Mariamma Joseph; Nick Yardley; Claire Temple
Journal:  Can J Plast Surg       Date:  2011

5.  Mohs' micrographic surgery of the head and neck.

Authors:  G L Darmstadt; H K Steinman
Journal:  West J Med       Date:  1990-02

6.  The principles of mohs micrographic surgery for cutaneous neoplasia.

Authors:  Eric M Finley
Journal:  Ochsner J       Date:  2003

Review 7.  Basal cell carcinoma.

Authors:  Anthony Ormerod; Sanjay Rajpara; Fiona Craig
Journal:  BMJ Clin Evid       Date:  2010-04-06

8.  The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.

Authors:  Mara Ozolins; Hywel C Williams; Sarah J Armstrong; Fiona J Bath-Hextall
Journal:  Trials       Date:  2010-04-21       Impact factor: 2.279

9.  The woman with unexplained anaemia.

Authors:  Nada Al-Hadithy; James Coelho; Mark Gorman; Christopher Stone
Journal:  BMJ Case Rep       Date:  2015-12-15

10.  Adenoid type of Basal cell carcinoma: rare histopathological variant at an unusual location.

Authors:  Swagata A Tambe; Smita S Ghate; Hemangi R Jerajani
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.